| Gene symbol | CSF2RA | Synonyms | CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMCSFR-alpha, GMR, GMR-alpha, SMDP4, alphaGMR | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | colony stimulating factor 2 receptor subunit alpha | ||||
| GTO ID | GTC1392 |
| Trial ID | NCT01438112 |
| Disease | Bladder Cancer |
| Altered gene | CSF-2R |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | CG0070 |
| Phase | Phase2|Phase3 |
| Recruitment status | Terminated |
| Title | An Integrated Phase II/III, Open Label, Randomized and Controlled Study of the Safety and Efficacy of CG0070 Adenovirus Vector Expressing GM-CSF in Patients With NMIBC With Carcinoma In Situ Disease Who Have Failed BCG |
| Year | 2011 |
| Country | United States |
| Company sponsor | CG Oncology, Inc. |
| Other ID(s) | 12154 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||